-

Pharma Innovator Modernizes Cleaning Validation with ValGenesis iClean™

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, today announced that an international pharmaceutical company has selected ValGenesis iClean™ to modernize its cleaning validation operations and enhance compliance.

ValGenesis iClean™ streamlines cleaning process design and execution through risk-based strategies and compliant evidence capture, reducing the operational burden associated with large, paper-based validation programs.

Share

ValGenesis iClean™ is a purpose-built application within the ValGenesis Validation Lifecycle Suite (VLS), used by global pharmaceutical organizations to digitalize cleaning validation operations across manufacturing facilities. iClean streamlines cleaning process design and execution through risk-based strategies and compliant evidence capture, reducing the operational burden associated with large, paper-based validation programs.

The application will support the oversight of more than a dozen active pharmaceutical ingredients, scaling alongside the company’s growing product portfolio while enabling more robust toxicity- and solubility-based risk assessments and preserving critical process knowledge in a centralized system. The implementation marks the beginning of a broader digital transformation initiative, starting at a single manufacturing site and expanding to additional sites over time.

“This partnership reflects how pharmaceutical organizations are embracing digital solutions to bring greater rigor and scalability to cleaning validation,” said Steve Reynolds, chief revenue officer at ValGenesis. “With iClean, customers can replace manual spreadsheets with a compliant, data-driven approach that not only centralizes cleaning data but also streamlines execution and improves the efficiency of day-to-day validation operations.”

About ValGenesis, Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com.

Contacts

For further information, contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis Inc.


Release Versions

Contacts

For further information, contact:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis Inc.

Global CRDMO Selects ValGenesis to Digitalize Validation at Greenfield Facility

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in enterprise digital validation, announced that a global contract research, development, and manufacturing organization (CRDMO) has selected ValGenesis to digitalize validation activities at its greenfield facility in a rapidly growing APAC biopharmaceutical manufacturing hub. The implementation is part of the organization’s broader effort to modernize validation practices, expand automation, and strengthen data integrit...

ValGenesis Appoints Wayne Baker as Chief Revenue Officer to Accelerate Global Growth

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis appoints Wayne Baker as chief revenue officer to lead global revenue strategy and accelerate Smart GxP and VAL adoption....

Leading Public Health Organization Implements ValGenesis Platform

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in enterprise digital validation, announced that a leading public health organization has gone live with ValGenesis, marking a significant milestone in its mission to strengthen global health research and preparedness. The organization conducts research focused on addressing infectious diseases and emerging global health challenges, contributing to scientific advancement and improved public health outcomes worldwide. The...
Back to Newsroom